RETRACTED: PEDF and 34‐mer peptide inhibit cardiac microvascular endothelial cell ferroptosis via Nrf2/ HO ‐1 signalling in myocardial ischemia‐reperfusion injury
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18558 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Peng Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Serpins, Nerve Growth Factors, NF-E2-Related Factor 2, Ferroptosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Social Development Projects of Medical and Health Programs in Xuzhou city, Key Project of Affiliated Hospital of Xuzhou Medical University.
Abstract (Originalsprache)
Myocardial ischemia‐reperfusion injury (MIRI) represents a critical pathology in acute myocardial infarction (AMI), which is characterized by high mortality and morbidity. Cardiac microvascular dysfunction contributes to MIRI, potentially culminating in heart failure (HF). Pigment epithelium‐derived factor (PEDF), which belongs to the non‐inhibitory serpin family, exhibits several physiological effects, including anti‐angiogenesis, anti‐inflammatory and antioxidant properties. Our study aims to explore the impact of PEDF and its functional peptide 34‐mer on both cardiac microvascular perfusion in MIRI rats and human cardiac microvascular endothelial cells (HCMECs) injury under hypoxia reoxygenation (HR). It has been shown that MIRI is accompanied by ferroptosis in HCMECs. Furthermore, we investigated the effect of PEDF and its 34‐mer, particularly regarding the Nrf2/HO‐1 signalling pathway. Our results demonstrated that PEDF 34‐mer significantly ameliorated cardiac microvascular dysfunction following MIRI. Additionally, they exhibited a notable suppression of ferroptosis in HCMECs, and these effects were mediated through activation of Nrf2/HO‐1 signalling. These findings highlight the therapeutic potential of PEDF and 34‐mer in alleviating microvascular dysfunction and MIRI. By enhancing cardiac microvascular perfusion and mitigating endothelial ferroptosis, PEDF and its derivative peptide represent promising candidates for the treatment of AMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
- Department of Cardiovascular Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
ORCID-Profile: Yanliang Yuan
Förderung
- Social Development Projects of Medical and Health Programs in Xuzhou city
- Key Project of Affiliated Hospital of Xuzhou Medical University
Zitieren
APA
Lu, P., Qi, Y., Li, X., Zhang, C., Chen, Z., Shen, Z., Liang, J., Zhang, H., & Yuan, Y. (2024). RETRACTED: PEDF and 34‐mer peptide inhibit cardiac microvascular endothelial cell ferroptosis via Nrf2/ HO ‐1 signalling in myocardial ischemia‐reperfusion injury. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18558
Vancouver
Lu P, Qi Y, Li X, Zhang C, Chen Z, Shen Z, et al. RETRACTED: PEDF and 34‐mer peptide inhibit cardiac microvascular endothelial cell ferroptosis via Nrf2/ HO ‐1 signalling in myocardial ischemia‐reperfusion injury. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18558
BibTeX
@article{Lu2024,
author = {Lu, Peng and Qi, Yuanpu and Li, Xiangyu and Zhang, Cheng and Chen, Zhipeng and Shen, Zihao and Liang, Jingtian and Zhang, Hao and Yuan, Yanliang},
title = {RETRACTED: PEDF and 34‐mer peptide inhibit cardiac microvascular endothelial cell ferroptosis via Nrf2/ HO ‐1 signalling in myocardial ischemia‐reperfusion injury},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18558}
}
EUVIMED